Several studies agree with the demonstration that circulating Tregs count is increased in CLL patients with respect to healthy controls, while data on Tregs frequency among total CD4+ T cells are not consistent (116–119). This evidence concerns the gene CD4 and B-cell chronic lymphocytic leukemia.